한빛사 논문
Bo-Hyun Youa,1, Jung-Ho Yoonb,1, Hoin Kangc, Eun Kyung Leec, Sang Kil Leeb,d,2, and Jin-Wu Nama,e,2
a Department of Life Science, College of Natural Sciences, Hanyang University, 04763 Seoul, Republic of Korea; b Division of Gastroenterology, Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, 03722 Seoul, Republic of Korea; c Department of Biochemistry, College of Medicine, The Catholic University of Korea, 06591 Seoul, Republic of Korea; d Brain Korea 21 PLUS Project for Medical Science, Yonsei University, 03722 Seoul, Republic of Korea; and e Research Institute for Convergence of Basic Sciences, Hanyang University, 04763 Seoul, Republic of Korea
1 B.-H.Y. and J.-H.Y. contributed equally to this work.
2 To whom correspondence may be addressed.
Abstract
Wnt signaling through both canonical and noncanonical pathways plays a core role in development. Dysregulation of these pathways often causes cancer development and progression. Although the pathways independently contribute to the core processes, a regulatory molecule that commonly activates both of them has not yet been reported. Here, we describe a long noncoding RNA (lncRNA), HERES, that epigenetically regulates both canonical and noncanonical Wnt signaling pathways in esophageal squamous cell carcinoma (ESCC). For this study, we performed RNA-seq analysis on Korean ESCC patients and validated these results on a larger ESCC cohort to identify lncRNAs commonly dysregulated in ESCCs. Six of the dysregulated lncRNAs were significantly associated with the clinical outcomes of ESCC patients and defined 4 ESCC subclasses with different prognoses. HERES reduction repressed cell proliferation, migration, invasion, and colony formation in ESCC cell lines and tumor growth in xenograft models. HERES appears to be a transacting factor that regulates CACNA2D3, SFRP2, and CXXC4 simultaneously to activate Wnt signaling pathways through an interaction with EZH2 via its G-quadruple structure-like motif. Our results suggest that HERES holds substantial potential as a therapeutic target for ESCC and probably other cancers caused by defects in Wnt signaling pathways.
epigenetic regulation, long noncoding RNA, Wnt signaling pathway, esophageal squamous cell carcinoma
논문정보
관련 링크
연구자 키워드
관련분야 연구자보기
관련분야 논문보기